ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
ImaScientist
|
253 |
65K |
0 |
28/08/22 |
28/08/22 |
ASX - By Stock
|
253
|
65K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
ImaScientist
|
253 |
65K |
2 |
28/08/22 |
28/08/22 |
ASX - By Stock
|
253
|
65K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
ImaScientist
|
253 |
65K |
0 |
28/08/22 |
28/08/22 |
ASX - By Stock
|
253
|
65K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
NCT04214093...at last we get the full picture
|
|
ImaScientist
|
11 |
4.8K |
1 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
11
|
4.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ceasing to be a substantial holder
|
|
ImaScientist
|
48 |
14K |
10 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
48
|
14K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ImaScientist
|
17K |
6.6M |
54 |
24/04/22 |
24/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
54
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ImaScientist
|
17K |
6.6M |
26 |
24/04/22 |
24/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
26
|
|
ASX - By Stock
|
SPL |
Re:
Message to the TGA
|
|
ImaScientist
|
58 |
17K |
7 |
18/04/22 |
18/04/22 |
ASX - By Stock
|
58
|
17K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Message to the TGA
|
|
ImaScientist
|
58 |
17K |
14 |
17/04/22 |
17/04/22 |
ASX - By Stock
|
58
|
17K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ImaScientist
|
17K |
6.6M |
32 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3G and Appendix 3H
|
|
ImaScientist
|
48 |
19K |
30 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
48
|
19K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ImaScientist
|
17K |
6.6M |
60 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
60
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ImaScientist
|
17K |
6.6M |
54 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
17K
|
6.6M
|
54
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
ImaScientist
|
34 |
14K |
20 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
34
|
14K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
ImaScientist
|
144 |
56K |
54 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
144
|
56K
|
54
|
|
ASX - By Stock
|
SPL |
Re:
OMICRON SUB VARIANT BA2 creating havic No Masks and no VIRALEZE™ nasal spray
|
|
ImaScientist
|
39 |
10K |
2 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
39
|
10K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 in VIRALEZE virucidal against Omicron
|
|
ImaScientist
|
62 |
16K |
3 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
62
|
16K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ulcerative Colitis & Crohns Results Presented at ECCO
|
|
ImaScientist
|
202 |
84K |
20 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
202
|
84K
|
20
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE distribution in Saudi Arabia - supplementary info
|
|
ImaScientist
|
68 |
16K |
4 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
68
|
16K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ImaScientist
|
17K |
6.6M |
11 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
17K
|
6.6M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ImaScientist
|
17K |
6.6M |
5 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
17K
|
6.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
ImaScientist
|
267 |
64K |
19 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
267
|
64K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
ImaScientist
|
880 |
212K |
22 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
880
|
212K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
ImaScientist
|
880 |
212K |
30 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
880
|
212K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
ImaScientist
|
880 |
212K |
47 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
880
|
212K
|
47
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze: TGA and Aust government negiligence
|
|
ImaScientist
|
116 |
26K |
6 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
116
|
26K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
ImaScientist
|
850 |
249K |
36 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
850
|
249K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
ImaScientist
|
373 |
87K |
23 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
373
|
87K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Biotech Showcase 2022 Presentation
|
|
ImaScientist
|
39 |
14K |
16 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
39
|
14K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain
|
|
ImaScientist
|
373 |
87K |
48 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
373
|
87K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
ImaScientist
|
408 |
122K |
26 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
408
|
122K
|
26
|
|
ASX - By Stock
|
SPL |
Re:
Marketing of VIRALEZE ™ in Vietnam
|
|
ImaScientist
|
151 |
45K |
6 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
151
|
45K
|
6
|
|
ASX - By Stock
|
TTT |
Re:
TTT media
|
|
ImaScientist
|
1.4K |
622K |
5 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
1.4K
|
622K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
ImaScientist
|
451 |
113K |
8 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
451
|
113K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
ImaScientist
|
451 |
113K |
13 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
451
|
113K
|
13
|
|
ASX - By Stock
|
SPL |
Re:
Tone deaf Board of Directors?
|
|
ImaScientist
|
7 |
1.9K |
4 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
7
|
1.9K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
ImaScientist
|
1.0K |
270K |
15 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
1.0K
|
270K
|
15
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma to present at Bell Potter Healthcare Conference
|
|
ImaScientist
|
38 |
8.6K |
10 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
38
|
8.6K
|
10
|
|
ASX - By Stock
|
SPL |
Re:
Peter Mac Alliance
|
|
ImaScientist
|
6 |
1.9K |
1 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
6
|
1.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Peter Mac Alliance
|
|
ImaScientist
|
6 |
1.9K |
1 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
6
|
1.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Improves Survival in High-Risk Acute GvHD
|
|
ImaScientist
|
116 |
48K |
21 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
116
|
48K
|
21
|
|
ASX - By Stock
|
SPL |
Re:
Read Between the Lines
|
|
ImaScientist
|
50 |
9.5K |
3 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
50
|
9.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Updated VIRALEZE™ information
|
|
ImaScientist
|
177 |
44K |
9 |
29/09/21 |
29/09/21 |
ASX - By Stock
|
177
|
44K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Updated VIRALEZE™ information
|
|
ImaScientist
|
177 |
44K |
5 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
177
|
44K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Updated VIRALEZE™ information
|
|
ImaScientist
|
177 |
44K |
7 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
177
|
44K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Anti Mgt Rethoic
|
|
ImaScientist
|
20 |
5.8K |
7 |
26/09/21 |
26/09/21 |
ASX - By Stock
|
20
|
5.8K
|
7
|
|
ASX - By Stock
|
TTT |
Re:
Ann: Investor Roadshow Presentation
|
|
ImaScientist
|
32 |
12K |
7 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
32
|
12K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Updated VIRALEZE™ information
|
|
ImaScientist
|
177 |
44K |
4 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
177
|
44K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Updated VIRALEZE™ information
|
|
ImaScientist
|
177 |
44K |
6 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
177
|
44K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
ImaScientist
|
206 |
62K |
36 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
206
|
62K
|
36
|
|